𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy

✍ Scribed by JuliáN Panés; Josep M. Piqué; Josep M. Bordas; Maria Casadevall; Josep Terés; Jaime Bosch; Juan Rodés

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
648 KB
Volume
20
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of propranolol on gastric mucosa
Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy
✍ Julián Panés; Josep M. Bordas; Josep M. Piqué; Juan C. García-pagán; Faust Feu; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

This study investigated the effects of the short-term administration of propranolol on gastric blood perfusion in cirrhotic patients with portal hypertensive gastropathy. Portal hypertensive gastropathy is a common cause of nonvariceal bleeding in cirrhosis, which is associated with increased gastri

Reduction of gastric hyperemia by glypre
Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy
✍ Julián Panés; Josep M. Piqué; Josep M. Bordas; Josep Llach; Jaime Bosch; Josep T 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

## AND JCAN RODES~ Gastric mucosal perfusion is increased in portalhypertensive gastropathy, and this may contribute to gastric bleeding from these lesions. Therefore drugs reducing gastric mucosal perfusion may be beneficial in the treatment of overt bleeding from portal-hypertensive gastropathy.

Effects of bolus injections and continuo
Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: A double-blind hemodynamic investigation
✍ Isabel Cirera; Faust Feu; Angelo Luca; Joan C. García-Pagan; Mercedes Fernández; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

The present double-blind study was aimed at investigating the hemodynamic and humoral effects of somatostatin or placebo in patients with cirrhosis. Patients were randomly assigned to receive either an injection of 250 pg of somatostatin followed by a constant infusion of somatostatin at 250 pg/h (n